))
As an inaugural member of the Milken Institute FasterCures LeadersLink Program, RRP’s Executive Director Dr. Katrin Ericson created this podcast series to share the human story behind the challenges and successes of healthcare leaders who have made significant advances in the diseases they are driven to cure. Episodes include discussions with representatives from non-profit, pharma/biotech, venture capital, regulatory agencies, academia and more.
…
continue reading
Dr. Hugh Rienhoff has been many things in his life: an English major, a mathematician, a venture capital representative, a clinical physician scientist and an entrepreneur. But most important of all is being a father to daughter Bea, who was born with a very rare disease that doctors could not identify. Listen in as he shares with RRP's Executive D…
…
continue reading
From her childhood dream of becoming an astronaut to taking on a real life fight with her sister’s cancer diagnosis, Dr. Louise Perkins' deep love of science has been an obvious influence on the trajectory of both her personal life and professional career. Listen as she describes how she moved from a research bench into nonprofit leadership, what s…
…
continue reading
“I did it because we had to.” That is how current Amicus CEO John Crowley sums up his decision to leave his job and become the Co-founder, President and CEO of a biotech start-up that conducted research on a new experimental treatment for Pompe disease, which he credits as ultimately saving his children’s lives. Listen in as Crowley shares more abo…
…
continue reading
Michael Kaplan, CEO of the Melanoma Research Alliance, has headed nonprofits and patient advocacy groups across the United States and internationally, as well as managed international and domestic grant-making portfolios focused on disease surveillance, prevention and treatment. In this episode, he shares how his 25 years of experience battling on …
…
continue reading
Dr. David Fajgenbaum, co-founder and Executive Director of the Castleman Disease Collaborative Network (CDCN), shares his personal battle with this rare disease that almost took his life four times, as well as his tireless research that led to the discovery of a life-saving treatment for himself and other patients.…
…
continue reading
Are you a hedgehog or a fox? Dr. Dave Reese, executive vice president of Research and Development at Amgen, discusses the importance of pivoting during a pandemic, improving future drug success rates with big data, and his advice on leadership style for those working to cure diseases.
…
continue reading
How salad dressing and a special summer camp lured EB Research Partnership CEO Michael Hund away from becoming an attorney and into a career in fundraising, eventually leading him into venture philanthropy and the quest to find a cure for children with the rare and excruciating skin disease Epidermolysis Bullosa.…
…
continue reading
